| Literature DB >> 8156976 |
L Gram1.
Abstract
Controlled studies of oxcarbazepine (OCBZ) and the largest of the open studies of OCBZ were reviewed. The overall results indicated that OCBZ has the same clinical effect as carbamazepine (CBZ) but causes fewer adverse effects. Studies of allergic toxicity seem to indicate that OCBZ may be tolerated in the majority of patients developing allergy towards CBZ. We concluded that OCBZ is a drug of first choice for the treatment of epilepsy.Entities:
Mesh：
Substances：
Year: 1994 PMID： 8156976 DOI： 10.1111/j.1528-1157.1994.tb05942.x
Source DB: PubMed Journal: Epilepsia ISSN： 0013-9580 Impact factor: 5.864